interferon-lambda cures persistent murine norovirus infection absence adaptive immunity 
norovirus gastroenteritis major public health burden worldwide although fecal shedding important transmission enteric viruses little known immune factors restrict persistent enteric infection report although cytokines interferon-alpha ifn-alpha ifn-beta prevented systemic spread murine norovirus mnov ifn-lambda controlled persistent enteric infection infection-dependent induction ifn-lambda governed mnov capsid protein correlated diminished enteric persistence treatment established infection ifn-lambda cured mice manner requiring nonhematopoietic cell expression ifn-lambda receptor ifnlr1 independent adaptive immunity results suggest therapeutic potential ifn-lambda curing virus infections gastrointestinal tract 
